LONGITUDINAL MONITORING OF HAEMATOLOGICAL CANCERS IN THE UK: THE HAEMATOLOGICAL MALIGNANCY
Authors: Daniel James Whitaker
DOI: 10.5281/zenodo.17404646
Published: July 2024
Abstract
<p><em>With diverse aetiologies, treatment pathways and outcomes, haematological malignancies comprise a heterogeneous group of over 60 cancers.<sup>1,2 </sup>Critically for epidemiology, appreciation of the similarities and differences within this complex cancer group only emerged in recent decades, as understanding about the relationship between the various haematological malignancies, the bone marrow, the immune system and the cellular and genetic basis of malignant transformation gradually increased</em></p>
Full Text
No full text available
Cite this Article
DOI: 10.5281/zenodo.17404646
References
- No references available.